TRAUMA PRIMES CELLS
TRAUMA PRIMES CELLS
批准号:
2624606
负责人:
ALDEN H. HARKEN
金额:
$84.11万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2001-03-31
中文摘要
我们的创伤中心拨款延续了我们第一笔资金的假设
循环:“创伤启动细胞。”这一更新设想了
五个项目。临床核心项目将继续作为创伤/MOF
注册表。然而,帕特·奥夫纳指出,输血,这是
我们最初被用作震惊的替代标记,独立预测
国防部。他提出,输血中的脂质在血液循环中处于初始状态
中性粒细胞。吉恩·摩尔的项目令人信服地展示了我们的
创伤后内脏低血症可能是第一个资金周期
不会转移人体内的细菌/内毒素。他目前假定
损伤后的肠道缺血启动了循环中的中性粒细胞和
远端血管内皮细胞。Shin Meng的项目承认
巨噬细胞在多器官功能衰竭中的中心作用
微囊化HSP-72转导巨噬细胞可控制其细胞毒作用
肿瘤坏死因子的产生。奥尔登·哈肯假设内源性肿瘤坏死因子的产生是通过
心脏直接损害心脏功能,延迟术后早期
创伤性器官修复并加重晚期多器官功能衰竭。Ani Banerjee的项目
假设描述后-的细胞信号语言
应激/损伤引发可以被识别并进行治疗操作。
除了创伤研究中心,我们把自己想象成一个创伤
研究培训中心。
英文摘要
Our center trauma grant continues the hypothesis of our first funding
cycle: "Trauma primes cells." This renewal envisions the interweaving of
five projects. The clinical core project will continues as a trauma/MOF
registry. Pat Offner has noted, however, that a blood transfusion, which
we initially used as a surrogate marker of shock, independently predicts
MOF. He proposes that lipids in transfused blood prime circulating
neutrophils. Gene Moore's project convincingly demonstrated during our
first funding cycle that post -traumatic splanchnic hypofusion probably
does not translocate bacteria/endotoxin in man. He currently postulates
that post-injury gut ischemia primes both circulating neutrophils and
distant vascular endothelial cells. Shin Meng's project recognizes the
central role of the macrophage in MOF and proposes that liposome
encapsulated HSP-72 transfer into macrophages can control their cytotoxic
TNF production. Alden Harken postulates that endogenous TNF production by
heart directly compromises cardiac function which delays early post-
traumatic organ repair and exacerbates late MOF. Ani Banerjee's project
postulates that the cell signaling language delineating post-
stress/injury priming can be identified and therapeutically manipulated.
In addition to a trauma research center, we envision ourselves a trauma
research training center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MYOCARDIAL RESPONSE TO INJURY
-
批准号:6585993
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2002
-
负责人:ALDEN H. HARKEN
-
依托单位:
MYOCARDIAL RESPONSE TO INJURY
-
批准号:6660110
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2002
-
负责人:ALDEN H. HARKEN
-
依托单位:
ADAPTIVE /MALADAPTIVE POST INJURY CARDIAC PRIMING
-
批准号:6340979
-
项目类别:
-
资助金额:$21.07万
-
财政年份:2000
-
负责人:ALDEN H. HARKEN
-
依托单位:
ADAPTIVE /MALADAPTIVE POST INJURY CARDIAC PRIMING
-
批准号:6107679
-
项目类别:
-
资助金额:$21.07万
-
财政年份:1999
-
负责人:ALDEN H. HARKEN
-
依托单位:
ADAPTIVE /MALADAPTIVE POST INJURY CARDIAC PRIMING
-
批准号:6296721
-
项目类别:
-
资助金额:$21.07万
-
财政年份:1999
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS SUPPLEMENT
-
批准号:2836763
-
项目类别:
-
资助金额:$20.02万
-
财政年份:1998
-
负责人:ALDEN H. HARKEN
-
依托单位:
ADAPTIVE /MALADAPTIVE POST INJURY CARDIAC PRIMING
-
批准号:6271804
-
项目类别:
-
资助金额:$16.82万
-
财政年份:1998
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:6320333
-
项目类别:
-
资助金额:$86.58万
-
财政年份:1998
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:6180461
-
项目类别:
-
资助金额:$108.5万
-
财政年份:1998
-
负责人:ALDEN H. HARKEN
-
依托单位:
MYOCARDIAL RESPONSE TO INJURY
-
批准号:6505070
-
项目类别:
-
资助金额:$18.67万
-
财政年份:1998
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:6519532
-
项目类别:
-
资助金额:$87.98万
-
财政年份:1998
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:2900801
-
项目类别:
-
资助金额:$91.32万
-
财政年份:1998
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:6657890
-
项目类别:
-
资助金额:$23.15万
-
财政年份:1998
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:6636078
-
项目类别:
-
资助金额:$116.88万
-
财政年份:1998
-
负责人:ALDEN H. HARKEN
-
依托单位:
GENOMIC PREMODULATION OF POST-TRAUMATIC RECOVERY
-
批准号:6240579
-
项目类别:
-
资助金额:$15.38万
-
财政年份:1997
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:2186782
-
项目类别:
-
资助金额:$75.37万
-
财政年份:1993
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:2186780
-
项目类别:
-
资助金额:$72.24万
-
财政年份:1993
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:2186781
-
项目类别:
-
资助金额:$76.35万
-
财政年份:1993
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:2392183
-
项目类别:
-
资助金额:$76.92万
-
财政年份:1993
-
负责人:ALDEN H. HARKEN
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:3106106
-
项目类别:
-
资助金额:$72.85万
-
财政年份:1993
-
负责人:ALDEN H. HARKEN
-
依托单位:
海外基金